Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851356 · ClinicalTrials.gov registry record
Brain Inflammation in Major Depressive Disorder Background
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 61
- Enrollment target
NCT01851356 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 61 participants.
The verdict
NCT01851356 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Background: \- Studies have shown that inflammation plays an important role in depression. Brain inflammation may contribute to depression, and may make it more difficult to treat some kinds of depression with current therapies. Researchers want to use magnetic resonance imaging (MRI) and positron emission tomography (PET) scanning to study inflammation in the brain. To do so, they will use a contrast agent, which is a chemical that can show inflammation during an imaging study. Objectives: \- To see if people with major depressive disorder have increased inflammation in the brain. Eligibility: \- Individuals at least 18 years of age who have major depressive disorder. Design: * Participants will be screened with a physical exam and medical history. They will provide blood samples before the scanning sessions. * Participants will have a PET scan after the screening visit. They will have a dose of the contrast agent before the study. This scan will look for possible brain inflammation. * Participants will also have an MRI scan. This scan will take pictures of the brain for comparison studies. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2013-05-08 |
| Est. Completion | 2018-03-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01851356
The ClinicalTrials.gov registry entry for NCT01851356 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01851356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01851356 about?
NCT01851356 is a clinical study titled "Brain Inflammation in Major Depressive Disorder Background". Background: \- Studies have shown that inflammation plays an important role in depression. Brain inflammation may contribute to depression, and may make it more difficult to treat some kinds of depression with current therapies. Researchers want to use magnetic resonance imaging (MRI) and positron ...
What is the current status of trial NCT01851356?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2013-05-08. Estimated completion is 2018-03-22.
Who is sponsoring clinical trial NCT01851356?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.